The mevalonate (MVA) pathway plays a critical role in cholesterol biosynthesis, protein prenylation, and metabolic reprogramming, all of which contribute to cancer progression and therapy resistance. ...

Understanding the impacts of genetic abnormalities on immune responses to tumors can inform immunogenomic-based precision medicine.

The renovations at the state's biggest health system will help create the Mass General Brigham Cancer Institute.

Harvard cited “substantial financial uncertainties driven by rapidly shifting federal policies.”

Docket for COMMONWEALTH OF MASSACHUSETTS v. Matthew Memoli, M.D., M.S., 1:25-cv-10338 — Brought to you by Free Law Project, a non-profit dedicated to creating high quality open legal information.

ALT: a cartoon says hey everybody an old man 's talking while bart simpson looks on

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Notice of Legislative Mandates in Effect for FY 2024 NOT-OD-24-110. NIH

Disregarding the increase of relative biological effectiveness (RBE) may raise the risk of acute and late adverse events after proton beam therapy (PB…

The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!

The Trump administration has put a hold on all federal financial grants and loans, affecting tens of billions of dollars in payments.

ALT: a metal ball is hanging from a string on a wooden sculpture

Researchers facing

Abstract. Mutations in the KRAS oncogene can mediate resistance to radiation. KRAS mutation (mut) driven tumors have been reported to express cancer stem cell (CSC)-like features and may harbor metabo...

This study describes an exceptional, alternative pathway of SCLC pathogenesis via chromothripsis and ecDNA in the absence of RB1 and TP53 mutations or smoking mutagenesis, defining a novel tumor type ...

Radiation therapy (RT) can shape the tumor immune microenvironment by releasing pro- and anti-inflammatory signals, which ultimately influence the antigenicity and adjuvanticity of a tumor.1-3 Accumul...